Larimar Therapeutics, Inc. Cash Equivalents, at Carrying Value
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:CashEquivalentsAtCarryingValue · last filed 2022-05-12
- 2022-03-31: Cash Equivalents, at Carrying Value $62.60M.
- 2021-09-30: Cash Equivalents, at Carrying Value $78.00M.
- 2021-06-30: Cash Equivalents, at Carrying Value $70.60M.
- 2019-12-31: Cash Equivalents, at Carrying Value $0.00.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2022-03-31 | $62.60M 10-Q · filed 2022-05-12 |
| 2021-09-30 | $78.00M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $70.60M 10-Q · filed 2021-08-12 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-04 |